|
Real-time Estimate
Cboe BZX
23:26:59 21/08/2026 +04
|
5-day change | 1st Jan Change | ||
| 29.50 USD | +3.93% |
|
+9.98% | +6.13% |
| 08-20 | Ultragenyx's gene therapy wins first FDA approval for rare metabolic disorder | RE |
| 08-05 | BofA Adjusts Price Target on Beam Therapeutics to $43 From $47 | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +3.93% | +9.98% | +7.81% | +6.32% | +6.13% | +83.76% | +24.14% | -72.37% | - | 2.84B | |
| +1.09% | +5.26% | +5.00% | +19.93% | +10.12% | +4.44% | +26.03% | -22.79% | +216.35% | 51.22B | |
| -1.33% | +2.27% | +13.67% | +35.52% | +161.57% | +471.11% | +597.49% | +701.62% | - | 45.38B | |
| +1.90% | +8.23% | +18.01% | +21.47% | +23.79% | +19.79% | +91.77% | +37.60% | +1,192.41% | 41.97B | |
| +1.10% | +9.29% | +28.28% | +53.93% | +14.74% | +39.51% | +20.66% | +1.67% | +237.69% | 42.15B | |
| -0.93% | -4.80% | +11.41% | +12.55% | +11.56% | +17.39% | +46.60% | -12.07% | +140.26% | 31.95B | |
| +0.42% | +2.83% | +0.13% | +3.24% | - | - | - | - | - | 16.73B | |
| +1.56% | +7.73% | +17.22% | +44.90% | +10.96% | +37.47% | +153.36% | +247.62% | +2,029.90% | 17.1B | |
| +0.03% | +3.41% | +4.57% | +16.36% | +16.73% | +7.12% | +35.49% | -38.78% | +95.15% | 14.76B | |
| +1.54% | +5.33% | +34.45% | +85.69% | +47.88% | +90.88% | +46.83% | -30.72% | +252.90% | 13.91B | |
| -0.75% | +6.22% | +4.01% | +48.67% | -4.90% | -1.37% | -30.35% | -29.26% | +126.68% | 13.45B | |
| -5.74% | -3.65% | +28.70% | +79.90% | +68.77% | +60.52% | +76.53% | -39.32% | - | 12.73B | |
| +0.05% | -0.13% | +0.94% | +52.64% | +22.95% | +33.90% | -8.10% | -39.73% | +169.82% | 11.26B | |
| +8.55% | +37.56% | +46.33% | +54.16% | +21.37% | -6.57% | - | - | - | 12.03B | |
| +3.74% | +2.84% | +18.68% | +7.61% | +27.99% | +713.37% | +1,634.44% | +26.82% | - | 10.18B | |
| -0.09% | +2.51% | +6.15% | +49.29% | +54.66% | +182.55% | +491.93% | +117.57% | - | 10.1B | |
| +1.60% | -0.88% | -13.36% | -3.14% | -15.45% | +63.14% | +498.12% | +254.09% | +2,395.10% | 10.95B | |
| +0.03% | +0.17% | +0.44% | +63.51% | +78.57% | +270.80% | +454.67% | - | - | 10.16B | |
| +1.41% | +4.62% | +12.17% | -20.98% | -24.30% | +38.51% | +52.77% | +53.43% | +76.81% | 9.76B | |
| +1.80% | -1.35% | +10.63% | +50.00% | +75.19% | +173.04% | +683.46% | +208.55% | +1,219.05% | 9.75B | |
| Average | +1.00% | +3.13% | +12.76% | +34.08% | +32.02% | +121.02% | +271.99% | +80.23% | +679.34% | 19.42B | |
| Weighted average by Cap. | +0.67% | +3.07% | +13.84% | +33.13% | +38.33% | +114.55% | +216.51% | +115.67% | +588.07% |
- Stock Market
- Stocks
- BEAM Stock
- Sector Beam Therapeutics Inc.
Select your edition
All financial news and data tailored to specific country editions
